• Facebook
  • Twitter
  • Events
  • News
  • Donate
Search
Hit enter to search or ESC to close
New Jersey Alliance for Clinical and Translational Science New Jersey Alliance for Clinical and Translational Science
  • Home
  • About
    • Mission
    • Membership
    • Affiliated Institutions
    • NJ ACTS Leadership
    • Cite the CTSA and Publications
    • CTSA Resources
    • Cores
  • Community
    • Our Services
    • Core Leadership & Advisory Council
    • Volunteering for a Clinical Trial FAQs
    • How to Find a Clinical Trial
    • Partnership & Innovation Funding Opportunities
    • COVID-19 Resources
  • Investigator Resources
    • Funding Opportunities
    • Biostatistics, Epidemiology, Research Design (BERD)
    • Informatics Services
    • Regulatory Knowledge & Support
    • Special Populations in Research
    • Team Science
    • Machine Learning
    • Biomarkers
    • COVID-19
    • ResearchMatch (RM)
    • Additional Resources
  • Education & Training
    • Workforce Development
    • Badges
    • Seminars, Workshops, Media Library
    • Promoting STEM in High School and Earlier
    • Undergraduate Education and Training
    • Enhancing Diversity
    • Beyond Traditional Graduate Courses
    • NJ ACTS Collaborative Graduate Programs
  • KL2 & TL1
    • KL2 Mentored Career Development Awards
    • TL1 Predoctoral/Postdoctoral Training Awards
  • Clinical Trials Office
    • CTO About
    • OnCore
    • Solutions
    • Services
    • Manage Studies
    • Resources
  • Contact Us
    • NJ ACTS Newsletter
Select Page
Experimental decoy drug tricks coronavirus, then destroys it.

Experimental decoy drug tricks coronavirus, then destroys it.

by William Jester | Dec 24, 2022 | Community, Covid, News

The coronavirus has been a shifty foe, with new variants and subvariants rapidly evolving to evade vaccines and treatments. Researchers at Boston’s Dana-Farber Cancer Institute are working on an experimental drug that takes one of the virus’ most dangerous traits —...
Drug Used for Sleep Disorders Is Linked to Higher Risk of Overdose in Teens, Young Adults.

Drug Used for Sleep Disorders Is Linked to Higher Risk of Overdose in Teens, Young Adults.

by William Jester | Dec 23, 2022 | Community, News

Teens and young adults who are treated for sleep disorders with benzodiazepines such as Xanax – a medication commonly prescribed to treat anxiety and insomnia – may be at a higher risk of overdose, according to Rutgers researchers. The study, published in JAMA Network...
Infectious Disease Expert Named National Academy of Inventors Fellow.

Infectious Disease Expert Named National Academy of Inventors Fellow.

by William Jester | Dec 23, 2022 | News

Maria Laura ‘Marila’ Gennaro, whose research focuses on diagnosing tuberculosis (TB) and the antibody response to the SARS-CoV-2 infection that causes COVID-19, has been recognized as an academic inventor making a tangible impact on quality of life, economic...
Valium, Xanax Prescriptions Could Raise Overdose Risk in Youth.

Valium, Xanax Prescriptions Could Raise Overdose Risk in Youth.

by William Jester | Dec 22, 2022 | Community, News

Teenagers and young adults who use benzodiazepines to treat insomnia may be at heightened risk of overdose, a new study finds. Benzodiazepines include anxiety medications like Ativan, Klonopin, Valium and Xanax, as well as prescription sleep aids such as estazolam...
Princeton START program for inclusive entrepreneurship welcomes its inaugural cohort of researchers.

Princeton START program for inclusive entrepreneurship welcomes its inaugural cohort of researchers.

by William Jester | Dec 22, 2022 | News

This program is part academic fellowship and part startup accelerator. The START Entrepreneurs will conduct academic research with faculty on campus and receive entrepreneurship education and mentorship while building fundable, early-stage new ventures such as startup...
« Older Entries

Recent Posts

  • Join Us for the RITMS Visiting Professor Lecture Series on Monday June 12th at 12pm!
  • New NJACTS Publication
  • New NJACTS Publication
  • What causes seasonal allergies, and what can you do about it?
  • Community-Engaged Undergraduate Scholars.

Archives

  • 2023
    • June
    • May
    • April
    • March
    • February
    • January
  • 2022
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2021
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2020
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2019
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2018
    • December

Categories

  • Community (1,610)
  • Covid (934)
  • News (2,054)
  • Pilots (18)
Rutgers logo

THIS SITE

About

Membership

Community

Investigator Resources

Education & Training

News

Events

Contact

CONTACT US

New Jersey Alliance For Clinical and Translational Science (NJ ACTS)
Contact RU – info at 732-445-info(4636)


  • Facebook

  • Twitter

  • YouTube

© 2019, New Jersey Alliance for Clinical and Translational Science (NJ ACTS). All rights reserved.| Privacy Policy

Rutgers, The State University of New Jersey, is an equal access/equal opportunity institution. Individuals with disabilities are encouraged to direct suggestions, comments, or complaints concerning any accessibility issues with Rutgers web sites to accessibility@rutgers.edu or complete the Report Accessibility Barrier or Provide Feedback Form.